Authors: | Wolchok, J. D.; Rollin, L.; Larkin, J. |
Article Title: | The authors reply |
Keywords: | cancer survival; treatment response; gene mutation; cancer combination chemotherapy; drug safety; drug withdrawal; monotherapy; unspecified side effect; letter; ipilimumab; melanoma; clinical decision making; b raf kinase; braf gene; nivolumab; human; priority journal |
Journal Title: | New England Journal of Medicine |
Volume: | 377 |
Issue: | 25 |
ISSN: | 0028-4793 |
Publisher: | Massachusetts Medical Society |
Date Published: | 2017-12-21 |
Start Page: | 2503 |
End Page: | 2504 |
Language: | English |
DOI: | 10.1056/NEJMc1714339 |
PROVIDER: | scopus |
PUBMED: | 29262279 |
DOI/URL: | |
Notes: | Letter -- Export Date: 1 February 2018 -- Source: Scopus |